Delving into the Latest Updates on Cenra, Inc. with Synapse

Overview

Tags

Nervous System Diseases

Congenital Disorders

Endocrinology and Metabolic Disease

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

5-HT receptor(Serotonin (5-HT) receptor)	1

The primary objective of this study was to evaluate the efficacy of the new WH-1 ointment therapy compared with Aquacel® Hydrofiber® dressing for the treatment of chronic diabetic foot ulcers for up to 16 weeks. Another objective of this study was to collect safety information including adverse events and clinical laboratory abnormalities.

Start Date07 Dec 2018

Sponsor / Collaborator

Choice Pharm Med Info Consultancy (Shanghai Co. Ltd.

[+2]

100 Clinical Results associated with Cenra, Inc.

Login to view more data

0 Patents (Medical) associated with Cenra, Inc.

Login to view more data

100 Deals associated with Cenra, Inc.

Login to view more data

100 Translational Medicine associated with Cenra, Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Other

Login to view more data